Tomoya Maeda

638 total citations
44 papers, 409 citations indexed

About

Tomoya Maeda is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Tomoya Maeda has authored 44 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 11 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Tomoya Maeda's work include Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Lymphoblastic Leukemia research (7 papers). Tomoya Maeda is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Acute Lymphoblastic Leukemia research (7 papers). Tomoya Maeda collaborates with scholars based in Japan, United States and United Kingdom. Tomoya Maeda's co-authors include Maho Ishikawa, Masami Bessho, Fumiharu Yagasaki, Yasushi Miyazaki, Shigeki Ohtake, Yoshihiro Hatta, Norio Asou, A Hiraoka, Takahiro Karasuno and Hiroyuki Nakamura and has published in prestigious journals such as Blood, Cancer and Scientific Reports.

In The Last Decade

Tomoya Maeda

38 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoya Maeda Japan 13 202 126 105 86 53 44 409
Franklin Fuda United States 11 145 0.7× 71 0.6× 68 0.6× 75 0.9× 57 1.1× 51 395
Philip Imus United States 12 361 1.8× 231 1.8× 94 0.9× 66 0.8× 58 1.1× 40 583
Ivan Pašić Canada 12 238 1.2× 121 1.0× 85 0.8× 164 1.9× 47 0.9× 80 514
Liam Whitby United Kingdom 14 310 1.5× 65 0.5× 110 1.0× 205 2.4× 69 1.3× 35 701
Joaquín Sánchez‐García Spain 10 169 0.8× 77 0.6× 46 0.4× 48 0.6× 65 1.2× 26 306
Yasuhiko Shibasaki Japan 10 179 0.9× 85 0.7× 27 0.3× 17 0.2× 46 0.9× 35 303
Nisha Nair United Kingdom 13 79 0.4× 61 0.5× 23 0.2× 112 1.3× 73 1.4× 40 442
David Martínez‐Cuadrón Spain 13 325 1.6× 164 1.3× 108 1.0× 214 2.5× 82 1.5× 56 537
Taisei Suzuki Japan 12 80 0.4× 56 0.4× 25 0.2× 101 1.2× 38 0.7× 46 461
Malek Aoudjhane France 6 349 1.7× 135 1.1× 152 1.4× 36 0.4× 64 1.2× 12 508

Countries citing papers authored by Tomoya Maeda

Since Specialization
Citations

This map shows the geographic impact of Tomoya Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Maeda more than expected).

Fields of papers citing papers by Tomoya Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Maeda. The network helps show where Tomoya Maeda may publish in the future.

Co-authorship network of co-authors of Tomoya Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Maeda. A scholar is included among the top collaborators of Tomoya Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Maeda. Tomoya Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maeda, Tomoya, Noriyuki Watanabe, Sachi Tanaka, et al.. (2025). Rare Capnocytophaga sputigena bacteremia in a patient with acute lymphoblastic leukemia. Journal of Infection and Chemotherapy. 31(9). 102771–102771.
2.
Nishiwaki, Satoshi, Isamu Sugiura, Shin Fujisawa, et al.. (2024). Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission. American Journal of Hematology. 99(5). 806–815. 6 indexed citations
3.
Maeda, Tomoya, Maho Ishikawa, Mika Kohri, et al.. (2022). Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation. International Journal of Hematology. 115(6). 898–901. 1 indexed citations
4.
Kurosawa, Saiko, Takuhiro Yamaguchi, Takehiko Mori, et al.. (2021). Prevalence of organ symptoms in allo-HCT survivors and their impact on work and daily life. 10(4). 172–182. 1 indexed citations
5.
Mori, Jinichi, Shizuo Kaji, H. Kawai, et al.. (2020). Assessment of dysplasia in bone marrow smear with convolutional neural network. Scientific Reports. 10(1). 14734–14734. 34 indexed citations
6.
Kohri, Mika, Kunihiro Tsukasaki, Naoki Takahashi, et al.. (2020). Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract. Leukemia Research. 91. 106336–106336. 15 indexed citations
7.
Maeda, Tomoya, Akira Matsuda, Mika Kohri, et al.. (2020). Prognostic impact of peripheral blood Wilms’ tumour 1 mRNA expression levels in response to azacytidine in MDS: A single-centre analysis. Leukemia Research Reports. 15. 100231–100231. 2 indexed citations
8.
Ebihara, Yasuhiro, Noriyuki Watanabe, Tomoya Maeda, et al.. (2019). False-positive blood culture results in patients with hematologic malignancies. Journal of Infection and Chemotherapy. 25(5). 404–406. 2 indexed citations
9.
Ishikawa, Maho, et al.. (2018). The Progression of Severe Aplastic Anemia to Hypoplastic Leukemia in a Long-Term Observation after the Administration of Pegylated rHuMGDF. Hematology Reports. 10(3). 7679–7679. 1 indexed citations
10.
Hatta, Yoshihiro, Shuichi Mizuta, Keitaro Matsuo, et al.. (2018). Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL. Annals of Hematology. 97(9). 1535–1545. 29 indexed citations
11.
Matsuda, Akira, Itsuro Jinnai, Takaya Ichimura, et al.. (2015). Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes. International Journal of Hematology. 103(2). 227–233. 2 indexed citations
12.
Matsuda, Akira, Maho Ishikawa, Tomoya Maeda, et al.. (2014). Hematologic improvements in a myelodysplastic syndromes with myelofibrosis (MDS-F) patient treated with azacitidine. Leukemia Research Reports. 3(1). 24–27. 2 indexed citations
13.
Iriyama, Noriyoshi, Norio Asou, Yasushi Miyazaki, et al.. (2014). Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome. Annals of Hematology. 93(6). 957–963. 10 indexed citations
14.
Iriyama, Noriyoshi, Yoshihiro Hatta, Jin Takeuchi, et al.. (2013). CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21). Leukemia Research. 37(9). 1021–1026. 35 indexed citations
15.
Mizuta, Shuichi, Keitaro Matsuo, Tomoya Maeda, et al.. (2012). Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL. Blood Cancer Journal. 2(5). e72–e72. 22 indexed citations
16.
Maeda, Tomoya, Maho Ishikawa, Yoshihiro Ito, et al.. (2012). [Aplastic anemia complicated with ulcerative colitis].. PubMed. 53(2). 224–8. 3 indexed citations
17.
Ishikawa, Maho, Fumiharu Yagasaki, Tomoya Maeda, et al.. (2007). A Novel Gene, ANKRD28 on 3p25, Is Fused with NUP98 on 11p15 in a Cryptic 3-Way Translocation of t(3;5;11)(p25;q35;p15) in an Adult Patient with Myelodysplastic Syndrome/Acute Myelogenous Leukemia. International Journal of Hematology. 86(3). 238–245. 19 indexed citations
18.
19.
Tsuchiyama, Junjiro, Kento Imajo, T. Yoshino, et al.. (2000). Recurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemia. Annals of Hematology. 79(5). 269–271. 3 indexed citations
20.
Kawakami, M, Seiji Ueda, Tomoya Maeda, et al.. (1997). Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 20(6). 485–490. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franklin Fuda Breakdown of academic impact, for papers by Philip Imus Breakdown of academic impact, for papers by Ivan Pašić Breakdown of academic impact, for papers by Liam Whitby Breakdown of academic impact, for papers by Joaquín Sánchez‐García Breakdown of academic impact, for papers by Yasuhiko Shibasaki Breakdown of academic impact, for papers by Nisha Nair Breakdown of academic impact, for papers by David Martínez‐Cuadrón Breakdown of academic impact, for papers by Taisei Suzuki Breakdown of academic impact, for papers by Malek Aoudjhane
Rankless by CCL
2026